Prevalence and mechanisms of quinolone resistance among selected nontyphoid salmonella isolated from food animals and humans in Korea

Foodborne Pathogens and Disease

Volumn 8, Issue 11, 2011, Pages 1199-1206

  Tamang, Migma Dorji ^a   Nam, Hyang Mi ^a   Kim, Aeran ^a   Lee, Hee Soo ^a   Kim, Tae Sun ^b   Kim, Min Ji ^b   Jang, Geum Chan ^a   Jung, Suk Chan ^a   Lim, Suk Kyung ^a  

^a Animal Plant and Fisheries Quarantine and Inspection Agency   (South Korea)

^b Gwangju Institute of Health and Environment   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ENROFLOXACIN; NALIDIXIC ACID; QUINOLONE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; QUINOLONE DERIVATIVE;

ACC(6') IB CR GENE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; DNA SEQUENCE; FOOD CONTAMINATION; GENE MUTATION; GYRA GENE; HUMAN; KOREA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARC GENE; PLASMID MEDIATED QUINOLONE RESISTANCE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; QEPA GENE; QNR GENE; SALMONELLA; ANIMAL; BOVINAE; CHICKEN; DRUG EFFECTS; FOOD CONTROL; GENETICS; ISOLATION AND PURIFICATION; MEAT; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; POINT MUTATION; POULTRY; SALMONELLA INFECTIONS; SWINE;

ANIMALIA; SALMONELLA; SALMONELLA TYPHIMURIUM;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIAL PROTEINS; CATTLE; CHICKENS; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; FOOD MICROBIOLOGY; HUMANS; KOREA; MEAT; MICROBIAL SENSITIVITY TESTS; NALIDIXIC ACID; POINT MUTATION; POULTRY; PREVALENCE; QUINOLONES; SALMONELLA; SALMONELLA INFECTIONS; SEQUENCE ANALYSIS, DNA; SWINE;

EID: 80155192441     PISSN: 15353141     EISSN: 15567125     Source Type: Journal    
DOI: 10.1089/fpd.2011.0899     Document Type: Article

References (31)

1. Aarestrup FM, Wiuff C, Mølbak K, and Threlfall EJ. Is it time to change fluoroquinolone breakpoints for Salmonella spp.? An-timicrob Agents Chemother 2003;47:827-829. (Pubitemid 36158126)
2. Angulo FJ, Johnson KR, Tauxe RV, and Cohen ML. Origins and consequences of antimicrobial-resistant nontyphoid Salmonella: implications for the use of fluoroquinolones in food animals. Microb Drug Resist 2000;6:77-83. (Pubitemid 30367854)
3. Bertrand S, Weill FX, Cloeckaert A, Vrints M, Mairiaux E, Praud K, Dierick K, Wildemauve C, Godard C, Butaye P, Imberechts H, Grimont PAD, and Collard JM. Clonal emergence of extended-spectrum b-lactamase (CTX-M-2)-producing Salmonella enterica serovar Virchow isolates with reduced susceptibilities to ciprofloxacin among poultry and humans in Belgium and France (2000 to 2003). J Clin Microbiol 2006;44: 2897-2903. (Pubitemid 44228587)
4. Cheong HJ, Lee YJ, Hwang IS, Kee SY, Cheong HW, Song JY, Kim JM, Park YH, Jung JH, and Kim WJ. Characteristics of non-typhoidal Salmonella isolates from human and broiler-chickens in southwestern Seoul, Korea. J Korean Med Sci 2007; 22:773-778.
5. Choi SH, Woo JH, Lee JE, Park SJ, Choo EJ, Kwak YG, Kim MN, Choi MS, Lee NY, Lee BK, Kim NJ, Jeong JY, Ryu J, and Kim YS. Increasing incidence of quinolone resistance in human non-typhoid Salmonella enterica isolates in Korea and mechanisms involved in quinolone resistance. J Antimicrob Che-mother 2005;56:1111-1114. (Pubitemid 43009829)
6. [CLSI] Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; 20th informational supplement. M100-S20-U. Wayne, PA: CLSI, 2010.
7. [CLSI] Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disc and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard, 3rd edition. M31-A3. Wayne, PA: CLSI, 2008.
8. Cui S, Li J, Sun Z, Hu C, Jin S, Li F, Guo Y, Ran L, and Ma Y. Characterization of Salmonella enterica isolates from infants and toddlers in Wuhan, China. J Antimicrob Chemother 2009; 63:87-94.
9. Giraud E, Baucheron S, and Cloeckaert A. Resistance to fluoro-quinolones in Salmonella: emerging mechanisms and resistance prevention strategies. Microbes Infect 2006;8:1937-1944. (Pubitemid 44144556)
10. Giraud E, Brisabois A, Martel JL, and Chaslus-Dancla E. Comparative studies of mutations in animal isolates and experimental in vitro-and in vivo-selected mutants of Salmonella spp. suggest a counter selection of highly fluoroquinolone-resistant strains in the field. Antimicrob Agents Chemother 1999;43: 2131-2137. (Pubitemid 29421189)
11. Gunell M, Webber MA, Kotilainen P, Lilly AJ, Caddick J, Jalava J, Huovinen P, Siitonen A, Hakanen AJ, and Piddock LJ. Mechanisms of resistance in nontyphoidal Salmonella enterica strains exhibiting a nonclassical quinolone resistance pheno-type. Antimicrob Agents Chemother 2009;53:3832-3836.
12. Hopkins KL, Davies RH, and Threlfall EJ. Mechanisms of qui-nolone resistance in Escherichia coli and Salmonella: recent developments. Int J Antimicrob Agents 2005;25:358-373. (Pubitemid 40558766)
13. Hwang IS, Song JY, Kim WJ, Jeong HW, Kim MS, and Cheong HJ. Prevalence and mechanisms of low level quinolone resistance among non-typhoidal Salmonella isolates from human and poultry/livestock in Korea: usefulness of nalidixic acid resistance test. Infect Chemother 2010;42:230-236.
14. Jacoby GA, Gacharna N, Black TA, Miller GH, and Hooper DC. Temporal appearance of plasmid-mediated quinolone resistance genes. Antimicrob Agents Chemother 2009;53:1665-1616.
15. Kang HY, Tamang MD, Seol SY, and Kim J. Dissemination of plasmid-mediated qnr, aac(6¢)-Ib-cr, and qepA genes among 16S rRNA methylase producing Enterobacteriaceae in Korea. J Bacteriol Virol 2009;39:173-182.
16. [KFDA] Korea Food and Drug Administration. Establishment of Control System of Antibiotics for Livestock. Seoul South Korea: KFDA. 2009.
17. Kim HB, Park CH, Kim CJ, Kim E-C, Jacoby GA, and Hooper DC. Prevalence of plasmid-mediated quinolone resistance determinants over a nine-year period. Antimicrob Agents Chemother 2009;53:639-645.
18. Lee HY, Su LH, Tsai MH, Kim SW, Chang HH, Jung SI, Park KH, Perera J, Carlos C, Tan BH, Kumarasinghe G, So T, Chongthaleong A, Hsueh PR, Liu JW, Song JH, and Chiu CH. High rate of reduced susceptibility to ciprofloxacin and cef-triaxone among nontyphoid Salmonella clinical isolates in Asia. Antimicrob Agents Chemother 2009;53:2696-2699.
19. Lee WC, Lee MJ, Kim JS, and Park SY. Foodborne illness outbreaks in Korea and Japan studied retrospectively. J Food Prot 2001;64:899-902.
20. Liebana E, Clouting C, Cassar C, Walker R, Threlfall EJ, Clifton-Hadley F, and Davies R. Comparison of gyrA mutations, cy-clohexane resistance, and the presence of class I integrons in Salmonella enterica from farm animals in England and Wales. J Clin Microbiol 2002;40:1481-1486. (Pubitemid 34279921)
21. Lim SK, Lee HS, Nam HM, Jung SC, Koh HB, and Roh IS. Antimicrobial resistance and phage types of Salmonella isolates from healthy and diarrheic pigs in Korea. Foodborne Pathog Dis 2009;6:981-987.
22. Mart́ýnez-Mart́ýnez L, Pascual A, and Jacoby GA. Quinolone resistance from a transferable plasmid. Lancet 1998;351:797-799. (Pubitemid 28112342)
23. Molbak K, Baggesen DL, Aarestrup FM, Ebbesen JM, Engberg J, Frydendahl K, Gernersmidt P, Petersen AM, and Wegener HC. An outbreak of multidrug-resistant, quinolone-resistant, Salmonella enterica serotype typhimurium DT104. N Engl J Med 1999;341:1420-1425. (Pubitemid 29513457)
24. Park CH, Robicsek A, Jacoby GA, Sahm D, and Hooper DC. Prevalence in the United States of aac(6¢)Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Che-mother 2006;50:3953-3955. (Pubitemid 44684926)
25. Robicsek A, Strahilevitz J, Jacoby GA, Macielag M, Abbanat D, Park CH, Bush K, and Hooper DC. Fluoroquinolone-modi-fying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med 2006;12:83-88. (Pubitemid 43050081)
26. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson M-A, Roy SL, Jones JL, and Griffin PM. Foodborne illness acquired in the United States: major pathogens. Emerg Infect Dis 2011;17:7-15.
27. Sjolund-Karlsson M, Folster JP, Pecic G, Joyce K, Medalla F, Rickert R, and Whichard J M. Emergence of plasmid-mediated quinolone resistance among non-Typhi Salmonella enterica isolates from humans in the United States. Antimicrob Agents Chemother 2009;53:2142-2144.
28. Strahilevitz J, Jacoby GA, Hooper DC, and Robicsek A. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev 2009;22:664-689.
29. Tamang MD, Seol SY, Oh JY, Kang HY, Lee JC, Lee YC, Cho DT, and Kim J. Plasmid-mediated quinolone resistance determinants qnrA, qnrB, and qnrS among clinical isolates of En-terobacteriaceae in a Korean hospital. Antimicrob Agents Chemother 2008;52:4159-4162.
30. Weinberger M and Keller N. Recent trends in the epidemiology of non-typhoid Salmonella and antimicrobial resistance: the Israeli experience and worldwide review. Curr Opin Infect Dis 2005;18:513-521. (Pubitemid 41634764)
31. Yamane K, Wachino J-I, Suzuki S, Kimura K, Shibata N, Kato H, Shibayama K, Konda T, and Arakawa Y. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob Agents Chemother 2007;51:3354-3360. (Pubitemid 350067551)